Budd-Chiari syndrome primary prevention

Budd-Chiari syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Budd-Chiari syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Budd-Chiari syndrome primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Budd-Chiari syndrome primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Budd-Chiari syndrome primary prevention
CDC on Budd-Chiari syndrome primary prevention
Budd-Chiari syndrome primary prevention in the news
Blogs on Budd-Chiari syndrome primary prevention
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Budd-Chiari syndrome primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Primary Prevention

Measures for the primary prevention of Budd-Chiari syndrome include:

• Effective treatment of predisposing conditions
• Chronic anticoagulation in patients with underlying hypercoagulable disorder
• Treat patients with an underlying myeloproliferative disorder with aspirin and hydroxyurea rather than anticoagulants such as warfarin.